IL-2 and Beyond in Cancer Immunotherapy

The development of the T- and natural killer (NK) cell growth factor IL-2 has been a sentinel force ushering in the era of immunotherapy in cancer. With the advent of clinical grade recombinant IL-2 in the mid-1980s, oncologists could for the first time directly manipulate lymphocyte populations wit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Interferon Cytokine Res
Hlavní autoři: Wrangle, John M., Patterson, Alicia, Johnson, C. Bryce, Neitzke, Daniel J., Mehrotra, Shikhar, Denlinger, Chadrick E., Paulos, Chrystal M., Li, Zihai, Cole, David J., Rubinstein, Mark P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc. 2018
Témata:
Reviews
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5815463/
https://ncbi.nlm.nih.gov/pubmed/29443657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jir.2017.0101
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky